On a Mission to Transform Early Cardiac Diagnostics
Introducing CADScor®System- an advanced acoustic-based diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care.*
Use CADScor® System to Risk Stratify Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*
Non-invasive and radiation free assessment with actionable results
Allow for immediate risk stratification prior to potential secondary evaluation
Quickly and easily rule-out significant CAD with at least 96% Confidence (Negative Predictive Value) ¹
CADScor® System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient’s coronary blood flow. The system calculates a patient-specific CAD-score, and couples it with risk factors to rapidly indicate the patient’s risk of significant coronary stenosis for immediate risk stratification, prior to potential secondary evaluation.1 CADScor® System has been used in over 47,000 patient assessments2 and has CE-marking and FDA De Novo clearance.
Physicians’ Experiences Using CADScor®System
CADScor® System Research, Development and Clinical studies
CADScor® System is based on 15+ years of R&D, covered by 45 patents, approved in Europe with CE-marking and has received FDA De Novo clearance as a diagnostic aid for symptomatic patients with suspected CAD. Multiple clinical studies with over 6,000 patients studied have been published to demonstrate CADScor® System’s performance.
Schedule a Demo of CADScor®System
Schedule a free demo of CADScor®System and learn how you can risk stratify significant CAD at point of care.*
Latest Press Releases
- User manual US-FDA v.12.Y, prevalence 10,7%
- Based on commercial patch use since 2017
- Bjerking LH et al. Eur Heart J. Published online September 1, 2024
*Rule-out with at least 96% confidence (NPV)